Effect of demographic factors, urinary peak flow rates, and boyarsky symptom scores on patient treatment choice in benign prostatic hyperplasia

By Kaplan S.A.   Goluboff E.T.   Olsson C.A.   Deverka P.A.   Chmiel J.J.  

Urology, Vol. 45, Iss. 3, 1995-03 ,pp. : 398-405

Elsevier

Access to resources Recommend Favorite

Nocturia and benign prostatic hyperplasia

By Yoshimura K.   Ohara H.   Ichioka K.   Terada N.   Matsui Y.   Terai A.   Arai Y.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 786-790

Elsevier

Access to resources Recommend Favorite

Latin American study on patient acceptance of the international prostate symptom score (IPSS) in the evaluation of symptomatic benign prostatic hyperplasia

By Netto N.R.   de Lima M.L.   de Andrade E.F.M.   Apuzzo F.   da Silva M.B.   Davidzon I.M.   Moises M.J.   Chamma E.J.   Bogado H.  

Urology, Vol. 49, Iss. 1, 1997-01 ,pp. : 46-49

Elsevier

Access to resources Recommend Favorite

Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years - how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?

By Hudson P.B.   Boake R.   Trachtenberg J.   Romas N.A.   Rosenblatt S.   Narayan P.   Geller J.   Lieber M.M.   Elhilali M.   Norman R.   Patterson L.   Perreault J.-P.   Malek G.H.   Bruskewitz R.C.   Roy J.B.   Ko A.   Jacobsen C.A.   Stoner E.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 690-695

Elsevier

Access to resources Recommend Favorite

Laser treatment of benign prostatic hyperplasia

By Kuntz Rainer  

World Journal of Urology, Vol. 25, Iss. 3, 2007-06 ,pp. : 241-247

Springer Publishing Company

Access to resources Recommend Favorite